CRON
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (June 8th, 2019)
A weekly review of only the most important news to impact your marijuana stocks portfolio.
The Gimme 20% Return – Aphria Extraction Hack Explained
Aphria (TSE: APHA) has an undervalued asset hiding in Leamington Ontario that could lead to an immediate 20% jump in…
Aurora Cannabis Q3 2019 Earnings Review – Holding Pattern Continues
Aurora (TSX: ACB) reported Q3 earnings and showed growth in revenue, gross profit while decreasing costs. However, concerns remain with…
Cronos Group Inks Concentrate Agreement With MediPharm Labs
Looking to find a steady supply of cannabis concentrate ahead of the impending legalization of edible products, Cronos Group Inc.…
Cronos Group Launches R&D Centre In Israel
As Canadian cannabis companies increasingly seek an expanded presence internationally for cultivation and research opportunities, Toronto-based Cronos Group Inc. (NASDAQ:…
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (April 27th, 2019)
The 17 Edible Products Coming to Canada Later This Year Bottom Line: The release of edibles should help reenergize…
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (April 20th, 2019)
A weekly review of the most important cannabis news to impact your portfolio; from the Canopy acquisition of Acreage to…
Organigram 2Q 2019 Earnings Review – Selling Cannabis Customers Want
Organigram (CVE: OGI) posted another strong quarter. As a smaller producer, their cannabis production capabilities are impressive and undervalued.
Canadian Cannabis Scorecard (Spring 2019)
Confused about which marijuana stocks are worth your money? The Canadian Cannabis Scorecard is your guide to separating the best…